Skip to content

Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block

Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation in Patients With Moderate vs. Deep Neuromuscular Block

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02888067
Enrollment
12
Registered
2016-09-02
Start date
2017-07-01
Completion date
2022-07-20
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-Frequency Jet Ventilation, Vocal Cord Resection

Keywords

Neuromuscular Blockade

Brief summary

The purpose of this study is to determine whether deep neuromuscular blockade provides better surgical conditions than moderate neuromuscular blockade in patients undergoing vocal cord resections requiring jet ventilation.

Detailed description

To optimize anatomical exposure and to minimize direct manipulation of local lesions endotracheal intubation often is avoided in patients undergoing vocal cord surgery. Instead intermittent so called jet ventilation is carried out by using the Hunsaker Mon-jet tube. The safe conduct of these procedures requires full muscle paralysis. In clinical practice, however, deep neuromuscular blockade (NMB) usually cannot be established for this relatively short surgery (\<1h) because of an increased risk of prolonged NMB and postoperative ventilation. The novel neuromuscular blockade reversal agent sugammadex may prove particularly useful in this patient population because it allows fast and reliable reversal of even deep NMB. Deeper muscle paralysis during vocal cord surgery may be associated with better surgical conditions. The purpose of this study is to determine whether deep neuromuscular blockade provides better surgical conditions than moderate neuromuscular blockade in patients undergoing vocal cord resections requiring jet ventilation.

Interventions

DRUGRocuronium bromide 0.5 mg/kg

Moderate neuromuscular blockade with rocuronium bromide

DRUGRocuronium bromide 1.0 mg/kg

Deep neuromuscular blockade with rocuronium bromide

DRUGSugammadex sodium 2 mg/kg

Reversal with sugammadex sodium

DRUGSugammadex sodium 4 mg/kg

Reversal with sugammadex sodium

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Thomas Schricker
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective vocal cord resection with an expected length of the procedure longer than 20 minutes and requiring jet ventilation

Exclusion criteria

* Patients younger than 18 years old * Patients unable to give written informed consent * Patients with known or suspected neuromuscular disease * Patients with allergies to medications to be used during anesthesia * Patients with a (family) history of malignant hyperthermia * Patients with renal insufficiency (serum creatinine \>2 times normal or a glomerular filtration rate \<60 ml/h)

Design outcomes

Primary

MeasureTime frameDescription
Five-point surgical rating scale (SRS)during surgery, an average period of 50 minutesSurgical conditions during surgery will be assessed by the surgeon using a five-point surgical rating scale at 10 minutes intervals

Secondary

MeasureTime frameDescription
Time to extubationDuring the stay in the operation room, an average of 60 minutesTime from reversal to optimal extubation conditions (TOF ratio \<0.9)
Heart rateDuring the stay in the operation and recovery room, an average of 4 hours
Arterial blood pressureDuring the stay in the operation and recovery room, an average of 4 hours
Oxygen saturationDuring the stay in the operation and recovery room, an average of 4 hours
Respiratory rateDuring the stay in the operation and recovery room, an average of 4 hours
Drug dosagesThrough study completion, an average of 4 hoursDrugs and dosages used during the study
Duration of surgeryDuring the stay in the operation room, an average of 50 minutes
Duration of post-anesthesia care unit (PACU) stayDuring the stay in the recovery room, an average of 3 hoursTime spent in the PACU
Pain scoreDuring the stay in the operation and recovery room, an average of 4 hoursOn an 11-point numerical rating scale from 0 = no pain, to 10 = most severe pain imaginable at PACU
Occurence of nausea/vomitingDuring the stay in the operation and recovery room, an average of 4 hours
SedationDuring the stay in the operation and recovery room, an average of 4 hoursOn a five-point scale ranging from 0 = normal alertness to 5 = not aroused by a painful stimulus at PACU
Body temperatureDuring the stay in the operation and recovery room, an average of 4 hours

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026